Real‐world Use of Dupilumab for 53 Patients With Atopic Dermatitis in Japan

Journal of Cutaneous Immunology and Allergy
doi 10.1002/cia2.12099
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Dupilumab for the Treatment of Atopic Dermatitis

Prescriber
Pharmacology
2018English

Alopecia Areata After Dupilumab for Atopic Dermatitis

JAAD Case Reports
Dermatology
2018English

Effectiveness of Dupilumab Treatment in 95 Patients With Atopic Dermatitis: Daily Practice Data

British Journal of Dermatology
DermatologyMedicine
2019English

Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Clinical Response and Quality of Life in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Single-Center Real-Life Experience

Journal of Clinical Medicine
2020English

Remission of Alopecia Universalis in a Patient With Atopic Dermatitis Treated With Dupilumab

JAAD Case Reports
Dermatology
2019English

535 New Regional Dermatoses During Dupilumab Therapy for Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy